Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Traditional Chinese medicine for treating lupus erythematosus and inhibiting glucocorticoid side effect and application of traditional Chinese medicine

A technology for glucocorticoids and lupus erythematosus, which can be used in antipyretics, drug combinations, and pharmaceutical formulas, and can solve problems such as little effect

Active Publication Date: 2012-05-02
吴斌
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] In the prior art, Chinese patents such as CN1387886 and CN1422643 disclose Chinese medicines and preparation methods, and Chinese medicine compositions (CN1733244, CN101850080) for preventing the side effects of glucocorticoids, and Chinese patent medicines currently on the market for treating SLE include Lupus Pills, Compound Gold buckwheat slices, etc.; the medicines disclosed in the above-mentioned patents or patented medicines all take detoxification and blood stasis as the main prescription principle, even if they also take into account nourishing kidney yin, their effect is minimal

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Traditional Chinese medicine for treating lupus erythematosus and inhibiting glucocorticoid side effect and application of traditional Chinese medicine
  • Traditional Chinese medicine for treating lupus erythematosus and inhibiting glucocorticoid side effect and application of traditional Chinese medicine
  • Traditional Chinese medicine for treating lupus erythematosus and inhibiting glucocorticoid side effect and application of traditional Chinese medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] The traditional Chinese medicine in this example includes the following components by mass percentage: Zhishouwu 6.81%, Shengdi 10.63%, Polygonatum 4.54%, Cornus officinalis 4.54%, Cortex Moutan 7.81%, Radix Paeoniae Rubra 14.66%, Artemisia annua 9.09%, Turtle shell 3.54% , Anemarrhena 9.09%, Phellodendron 9.09%, Viola 13.66%, Alisma 6.54%.

Embodiment 2

[0025] The traditional Chinese medicine of this embodiment includes the following components according to mass percentage: Zhishouwu 17.64%, Shengdi 8.82%, Polygonatum 8.84%, Cornus officinalis 8.84%, Cortex Moutan 5.88%, Radix Paeoniae Rubra 9.82%, Artemisia annua 5.88%, Turtle shell 5.88% , Anemarrhena 4.88%, Phellodendron 5.88%, Viola 11.76%, Alisma 5.88%.

Embodiment 3

[0027] The traditional Chinese medicine of this embodiment includes the following components in terms of mass percentage: Zhishouwu 13.33%, Shengdi 13.33%, Polygonatum 6.69%, Cornus officinalis 6.69%, Cortex Moutan 6.66%, Radix Paeoniae Rubra 13.33%, Artemisia annua 6.66%, Turtle shell 4.45% , Anemarrhena 6.66%, Phellodendron 8.88%, Viola 8.88%, Alisma 4.44%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a traditional Chinese medicine for treating lupus erythematosus and inhibiting glucocorticoid side effect and an application of the traditional Chinese medicine. The traditional Chinese medicine comprises the following components by weight percent: 6.81-17.62% of polygonum multiflorum, 8.82-13.33% of root of rehmannia, 4.54-8.84% of rhizoma polygonati, 4.54-8.84% of dogwood, 5.88-7.81% of moutan bark, 9.82-14.66% of root of common peony, 5.88-9.09% of sweet wormwood, 3.54-5.88% of turtle shell, 4.88-9.09% of rhizoma anemarrhenae, 4.88-9.09% of golden cypress, 8.88-13.66% of herba violae and 4.44-6.54% of rhizoma alismatis. The medicine is applied to treating lupus erythematosus, can be used by being coordinated with glucocorticoid, can treat systematic lupus erythematosus, can intervene the side effects induced when glucocorticoid in a large dose is used for treating the lupus erythematosus, has the efficacy of nourishing liver and kidney, nourishing yin, lessening fire, cooling blood, dissolving stasis, and treating both principal and secondary aspects of diseases, is safe and effective, and can be applied to preparing the medicament for treating lupus erythematosus and inhibiting glucocorticoid.

Description

technical field [0001] The invention relates to a compound traditional Chinese medicine for treating autoimmune diseases, in particular to a traditional Chinese medicine composition for treating systemic lupus erythematosus and suppressing side effects of hormones. Background technique [0002] Systemic lupus erythematosus (SLE) is a common autoimmune disease in rheumatology, with various and varied clinical manifestations, often involving multiple systems and organs, and is a diffuse disease characterized by immune inflammation. Connective tissue disease. It often occurs in women of childbearing age. At present, it is often difficult to control the progress of the disease with the simple application of traditional Chinese medicine in treatment. High-dose glucocorticoids are the basic medicine of Western medicine. Obvious adverse reactions such as Cushing's syndrome and metabolic disorders have become important factors affecting the clinical application of hormones. Accord...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/8969A61P29/00A61P37/02A61P43/00A61K35/56A61K35/586
Inventor 吴斌
Owner 吴斌
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products